Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 628)
Posted On: 03/06/2020 1:21:20 AM
Post# of 155038
Posted By: ohm20
Cytodyn's potential revenue for COVID-19 (coronavirus)

Both Taiwan and China want large amounts of leronlimab when it's proven to work with COVID-19.

With the large batch production that the CEO mentioned Samsung's cost to manufacture shouldn't be more than $25 per 700mg, the wholesale should be less than $100.

Overseas we might have a deal like Vyera with COGs +10% and 50% net sales. I would expect overseas retail to be around $600 per 700mg ($2400 total for coronavirus).

600,000 vials x $600 = $360,000,000 - 30% overhead = $252,000,000 / 2 = $144,000,000 - $25,200,000 (10% royalty net sales) = $118,800,000.

With Samsung using four bioreactors of 20 Kl capacity they should be able to produce 800,000 doses every two weeks.













(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site